108 related articles for article (PubMed ID: 26885661)
21. Surgical management for non-functional pancreatic neuroendocrine neoplasms with synchronous liver metastasis: A consensus from the Chinese Study Group for Neuroendocrine Tumors (CSNET).
Jin K; Xu J; Chen J; Chen M; Chen R; Chen Y; Chen Z; Cheng B; Chi Y; Feng ST; Fu D; Hou B; Huang D; Huang H; Huang Q; Li J; Li Y; Liang H; Lin R; Liu A; Liu J; Liu X; Lu M; Luo J; Mai G; Ni Q; Qiu M; Shao C; Shen B; Sheng W; Sun J; Tan C; Tan H; Tang Q; Tang Y; Tian X; Tong D; Wang X; Wang J; Wang J; Wang W; Wang W; Wang Y; Wu Z; Xue L; Yan Q; Yang N; Yang Y; Yang Z; Yin X; Yuan C; Zeng S; Zhang R; Yu X
Int J Oncol; 2016 Nov; 49(5):1991-2000. PubMed ID: 27826620
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification.
Burad DK; Kodiatte TA; Rajeeb SM; Goel A; Eapen CE; Ramakrishna B
World J Gastroenterol; 2016 Oct; 22(40):8956-8966. PubMed ID: 27833387
[TBL] [Abstract][Full Text] [Related]
25. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological impact of gross classification on solitary small hepatocellular carcinoma.
Tsujita E; Yamashita Y; Takeishi K; Matsuyama A; Maeda T; Tsutsui S; Matsuda H; Ishida T
Hepatogastroenterology; 2013 Oct; 60(127):1726-30. PubMed ID: 24627922
[TBL] [Abstract][Full Text] [Related]
27. [Clinical characteristics and malignant predictive factors of pancreatic neuroendocrine tumors].
Han JH; Kim MH; Moon SH; Park SJ; Park DH; Lee SS; Seo DW; Lee SK; Kim SC; Han DJ
Korean J Gastroenterol; 2009 Feb; 53(2):98-105. PubMed ID: 19237835
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
Sallinen V; Haglund C; Seppänen H
Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
31. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
[TBL] [Abstract][Full Text] [Related]
32. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
[TBL] [Abstract][Full Text] [Related]
34. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
[TBL] [Abstract][Full Text] [Related]
35. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
[TBL] [Abstract][Full Text] [Related]
36. Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors.
Qadan M; Ma Y; Visser BC; Kunz PL; Fisher GA; Norton JA; Poultsides GA
J Am Coll Surg; 2014 Feb; 218(2):188-95. PubMed ID: 24321190
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.
Chi Y; Du F; Zhao H; Wang JW; Cai JQ
World J Gastroenterol; 2014 Nov; 20(43):16252-7. PubMed ID: 25473180
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.
Furukori M; Imai K; Karasaki H; Watanabe K; Oikawa K; Miyokawa N; Taniguchi M; Furukawa H
World J Gastroenterol; 2014 Dec; 20(47):17949-54. PubMed ID: 25548493
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine tumors of pancreas: how can we apply the 2006 TNM proposal?
Mboti FB; Loi P; Nagy N; Myriam D; Gelin M; Closset J
Hepatogastroenterology; 2010; 57(98):344-8. PubMed ID: 20583440
[TBL] [Abstract][Full Text] [Related]
40. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
